The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to
pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

September 27, 2022

Centene settles with Texas Medicaid for $166 million arising from state allegations that the PBM overbilled for pharmacy services – at least the 12th such settlement since 2021

A report on September 19 by KHN noted that St. Louis-based Centene Corp. had reached a settlement with Texas for $165.6 million to settle claims that it had overcharged the state for Medicaid pharmacy services. According to the report, this is at least the 12th such settlement since 2021, but there may have been more, because many have been confidential. The Texas settlement was reached in July, but “hadn’t been publicly announced until [September 19] after KHN obtained a copy of the settlement through a Texas public records request and began asking questions.”

KHN reported that multiple states have filed suits against Centene, alleging overbilling of Medicaid programs for prescriptions and pharmacy services. Although “the total number of states is not publicly known,” KHN was aware of settlements with AR, IL, KS, MS, NH, NM, OH, TX, and WA “for a total of $475 million, according to news releases and settlement documents from attorneys general in those states.”

In a July filing with the SEC, Centene indicated it had set aside $1.25 billion in 2021 for potential settlements over pharmacy billing lawsuits from states.

In spite of the settlements, KHN noted that Ohio, Mississippi, and Texas have all continued their state Medicaid programs’ relationships with Centene. [Miller A, Young S. Centene to pay $166 million to Texas in Medicaid drug pricing settlement. KHN 2022 Sep 11;